Britain raps Pfizer over inflated epilepsy drug prices
August 06, 2015 at 02:47 AM EDT
LONDON, Aug 6 (Reuters) - Britain's competition watchdog alleged on Thursday that U.S. drugmaker Pfizer and Flynn Pharma had breached competition law by ramping up the cost of an epilepsy drug used by more than 50,000 British patients.
